Cargando…

Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium

BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Leal, Teresinha, Bergamini, Gabriella, Huaux, François, Panin, Nadtha, Noel, Sabrina, Dhooghe, Barbara, Haaf, Jeremy B., Mauri, Pierluigi, Motta, Sara, Di Silvestre, Dario, Melotti, Paola, Sorio, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108761/
https://www.ncbi.nlm.nih.gov/pubmed/27895643
http://dx.doi.org/10.3389/fimmu.2016.00499
_version_ 1782467413957148672
author Leal, Teresinha
Bergamini, Gabriella
Huaux, François
Panin, Nadtha
Noel, Sabrina
Dhooghe, Barbara
Haaf, Jeremy B.
Mauri, Pierluigi
Motta, Sara
Di Silvestre, Dario
Melotti, Paola
Sorio, Claudio
author_facet Leal, Teresinha
Bergamini, Gabriella
Huaux, François
Panin, Nadtha
Noel, Sabrina
Dhooghe, Barbara
Haaf, Jeremy B.
Mauri, Pierluigi
Motta, Sara
Di Silvestre, Dario
Melotti, Paola
Sorio, Claudio
author_sort Leal, Teresinha
collection PubMed
description BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulates P. aeruginosa-induced pro-inflammatory responses by modifying release of bacterial proteins. METHODS: We monitored inflammatory markers in lungs of CF mutant mice and their littermate controls in response to conditioned media (CM) collected from the reference P. aeruginosa PAO1 strain cultured in the presence or in the absence of azithromycin. A mass spectrometry-based proteomic approach was applied to examine whether the macrolide elicits a differential release of bacterial proteins. RESULTS: CM collected from azithromycin-untreated PAO1 cultures induced powerful pro-inflammatory neutrophil-dominated responses. Azithromycin attenuated the responses, mainly of macrophage chemoattractant protein-1, tumor necrosis factor-α, and interferon-γ, in CF but not in wild-type mice. Proteomic analysis showed that azithromycin upregulated an array of bacterial proteins including those associated with regulation of immune functions and with repair and resolution of inflammatory responses like the chaperone DnaK and the S-adenosylmethionine synthase, while it downregulated the extracellular heme acquisition protein HasA and the catalytic enzyme lysylendopeptidase. CONCLUSION: Supernatants collected from cultures of the bacterial strain PAO1 represent a novel experimental model to trigger in vivo lung inflammatory responses that should be closer to those obtained with live bacteria, but without bacterial infection. Combined with a bactericidal effect, complex regulation of bacterial innate immune and metabolic factors released in the cultured medium by the action of the macrolide can contribute to its anti-inflammatory effects.
format Online
Article
Text
id pubmed-5108761
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51087612016-11-28 Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium Leal, Teresinha Bergamini, Gabriella Huaux, François Panin, Nadtha Noel, Sabrina Dhooghe, Barbara Haaf, Jeremy B. Mauri, Pierluigi Motta, Sara Di Silvestre, Dario Melotti, Paola Sorio, Claudio Front Immunol Immunology BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulates P. aeruginosa-induced pro-inflammatory responses by modifying release of bacterial proteins. METHODS: We monitored inflammatory markers in lungs of CF mutant mice and their littermate controls in response to conditioned media (CM) collected from the reference P. aeruginosa PAO1 strain cultured in the presence or in the absence of azithromycin. A mass spectrometry-based proteomic approach was applied to examine whether the macrolide elicits a differential release of bacterial proteins. RESULTS: CM collected from azithromycin-untreated PAO1 cultures induced powerful pro-inflammatory neutrophil-dominated responses. Azithromycin attenuated the responses, mainly of macrophage chemoattractant protein-1, tumor necrosis factor-α, and interferon-γ, in CF but not in wild-type mice. Proteomic analysis showed that azithromycin upregulated an array of bacterial proteins including those associated with regulation of immune functions and with repair and resolution of inflammatory responses like the chaperone DnaK and the S-adenosylmethionine synthase, while it downregulated the extracellular heme acquisition protein HasA and the catalytic enzyme lysylendopeptidase. CONCLUSION: Supernatants collected from cultures of the bacterial strain PAO1 represent a novel experimental model to trigger in vivo lung inflammatory responses that should be closer to those obtained with live bacteria, but without bacterial infection. Combined with a bactericidal effect, complex regulation of bacterial innate immune and metabolic factors released in the cultured medium by the action of the macrolide can contribute to its anti-inflammatory effects. Frontiers Media S.A. 2016-11-15 /pmc/articles/PMC5108761/ /pubmed/27895643 http://dx.doi.org/10.3389/fimmu.2016.00499 Text en Copyright © 2016 Leal, Bergamini, Huaux, Panin, Noel, Dhooghe, Haaf, Mauri, Motta, Di Silvestre, Melotti and Sorio. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Leal, Teresinha
Bergamini, Gabriella
Huaux, François
Panin, Nadtha
Noel, Sabrina
Dhooghe, Barbara
Haaf, Jeremy B.
Mauri, Pierluigi
Motta, Sara
Di Silvestre, Dario
Melotti, Paola
Sorio, Claudio
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
title Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
title_full Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
title_fullStr Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
title_full_unstemmed Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
title_short Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
title_sort azithromycin attenuates pseudomonas-induced lung inflammation by targeting bacterial proteins secreted in the cultured medium
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108761/
https://www.ncbi.nlm.nih.gov/pubmed/27895643
http://dx.doi.org/10.3389/fimmu.2016.00499
work_keys_str_mv AT lealteresinha azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT bergaminigabriella azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT huauxfrancois azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT paninnadtha azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT noelsabrina azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT dhooghebarbara azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT haafjeremyb azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT mauripierluigi azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT mottasara azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT disilvestredario azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT melottipaola azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium
AT sorioclaudio azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium